Genomic Variation in Diffuse Large B Cell Lymphomas
Can it answer your research question?
1 of 6 supportedOverall survival
SupportedVital status and time are populated; median follow-up 5.1 years; 240 cases with follow-up; endpoint: overall survival.API
Progression or recurrence
Not supportedprogression_or_recurrenceis informative for no case in the harmonized records.APITreatment response
Not supportedtreatment_outcomeis populated for no case in the harmonized records.APIWhich drug was given
Not supportedtherapeutic_agentsis recorded for no case in the harmonized records.APIStage-adjusted modelling
Not supportedajcc_pathologic_stageis informative for no case in the harmonized records.APIAnalysis by race or ethnicity
Not supportedRace is informative for no case in the harmonized records.API
At a glance
Every percentage is the repository’s own record of what is filled inSubjectCALC
As filed by the repository
Who is in the cohortAPI
- Sex288 male · 201 female
- Race489 not reported
- Ethnicity489 not reported
- Vital status388 alive · 101 dead
Age at diagnosis
What was measured, and on how many
- Bulk RNA sequencing481 of 489 · 98%
- Targeted DNA panel sequencing485 of 489 · >99%
- Whole exome sequencing472 of 489 · 97%
- Structural Variation481 of 489 · 98%
How complete all 29 clinical fields are - 4 informative for at least 80% of cases
Outcome
Follow-up
Treatment
Diagnosis
Demographics
Access
Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required
- Open components
- 481 open-access files
- Controlled components
- 4,805 controlled-access files
- Typical turnaround
- days to a few weeks after signing official approval
- License
- NIH Genomic Data Sharing Policy terms
- Citation requirement
- Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.
What it is good for
Written and checked by a reviewer, not generated from metadata.
No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.
What it cannot tell you
Written by a reviewer against the source, not inferred from what is missing.
No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.
Who has used it
Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.
What articles did with it
- Cited the paper1,833
- Mentioned the dataset1
- Accession found in text0
- Declared using it7
- Analyzed the data24
Against comparable datasets
- Analyzed it24
- Expected~23
- Reuse is within the expected range for comparable datasets (index +0.05).
Original publication
Articles that analyzed the data
Community examples
Share your exampleAnalyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.
Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.
Start here
Starter code generated from this record’s own identifiers, then the access steps.
Get the data in code
GDC: list open files and download thempython
import json, requests
PROJECT = "NCICCR-DLBCL"
filters = {"op": "and", "content": [
{"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
{"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
"fields": "file_id,file_name,data_category,data_type,file_size",
"size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")
# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txtGDC: clinical table for every casepython
import json, requests
filters = {"op": "in", "content": {"field": "project.project_id", "value": ["NCICCR-DLBCL"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
"fields": ",".join([
"submitter_id", "demographic.vital_status", "demographic.days_to_death",
"diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
"diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("NCICCR-DLBCL_clinical.tsv", "w").write(tsv)This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-nciccr-dlbcl.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'Access steps
- Open the project in the GDC Data PortalFor people
Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.
https://portal.gdc.cancer.gov/projects/NCICCR-DLBCL - Download the open files without an accountFor people
481 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.
https://gdc.cancer.gov/access-data/gdc-data-transfer-toolgdc-client download -m gdc_manifest.txt - Request controlled access through dbGaPFor people
4,805 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs001444.
https://gdc.cancer.gov/access-data/obtaining-access-controlled-data - Download controlled files with your tokenFor people
An approved request yields a token. The same manifest fetches nothing controlled without it.
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001444gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt - Query the project from code, with no credentialsFor agents
The file index is public even where files are not, so an agent can size the cohort before anyone requests access.
https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/curl -s 'https://api.gdc.cancer.gov/files' --get \ --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["NCICCR-DLBCL"]}}' \ --data-urlencode 'fields=file_id,file_name,data_type' \ --data-urlencode 'size=10000' --data-urlencode 'format=TSV' - Pass the token when the agent needs controlled filesFor agents
Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.
https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
Provenance
All of it, and more, is in this record’s JSON.
Identifiers
- GDC projectNCICCR-DLBCLAPI
- GDC programAPI
- dbGaP studyphs001444API
Versions and verification
- Released
- 1 Jan 2018
- Metadata retrieved
- 18 Sept 2026
- Review status
- Machine-extracted
- Data generation funding
- Funded data generation
Funding
Funded data generation
- U01CA157581Molecular Diagnosis and Prognosis in Aggressive LymphomaLisa RimszaAPI2
Funded reuse of these data
- R01CA184185Stress Pathways in Tumors Drive Global MDSC Activity and Survival through ChopPaulo Cesar RodriguezAPI
- K23CA201594Breaking immune tolerance to Survivin in Multiple MyelomaFrederick LockeAPI
- R35CA210105From pathogenesis to new therapeutic targets in diffuse large B cell lymphomaRiccardo Dalla-FaveraAPI
- T32CA009566Basic Medical Research Training in OncologyOLUFUNMILAYO F. OLOPADE, Ezra CohenAPI
- R50CA211404Therapeutic insights through patient derived leukemia xenograftsMark WunderlichAPI
- R01CA280389TET2-mediated epitranscriptomic regulation in leukemia microenvironmentJianjun ChenAPI
- R01CA271497The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemiaJianjun ChenAPI
- R01CA243386Targeting FTO to treat acute myeloid leukemiaJianjun ChenAPI
- R01CA236399The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AMLJianjun ChenAPI
- R01CA214965The role and mechanism of FTO in leukemogenesis and drug responseJianjun ChenAPI
Funded infrastructure or harmonization
- P30CA076292Immuno-OncologyFrederick Locke, Christine O'ConnellAPI
- P30CA013696Developmental FundsAnil K Rustgi, Andrew B LassmanAPI
- P30CA008748Cancer Center AdministrationALEX MACDONALD, SELWYN M VICKERSAPI
- U01CA305196Mechanism and therapeutic implication of RNA-modification-mediated codon-biased translation in acute myeloid leukemiaJianjun Chen, XIAOLAN DENGAPI
- P30CA033572Leadership, Planning and EvaluationJOHN D. CARPTEN, Alex F. HerreraAPI
- P50CA171963Core A: Biospecimen ProcessingMEAGAN JACOBY, John F. DipersioAPI
- P01CA272295Epigenetic basis and therapeutic targeting of the unique lymphoma immunological nicheLeandro C Cerchietti, CHRISTOPHER R FLOWERSAPI
- P01CA229100Preclinical Models and Therapeutics CoreGiorgio Inghirami, Lisa RimszaAPI